Clinical Trials
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
View the study at Clinicaltrials.gov
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
View the study at Clinicaltrials.gov
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
View the study at Clinicaltrials.gov
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
View the study at Clinicaltrials.gov
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
View the study at Clinicaltrials.gov
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
View the study at Clinicaltrials.gov
A Randomized Phase III Trial of Weekly Paclitaxel Compared to Weekly Nanoparticle Albumin Bound NAB-Paclitaxel or Ixabepilone Combined with Bevacizumab as First-Line Therapy for Locally Recurrent or Metastatic Breast Cancer.
View the study at Clinicaltrials.gov
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
View the study at Clinicaltrials.gov
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
View the study at Clinicaltrials.gov
A Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab (IMC-1121B) Drug Product vs. mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, or Stomach.
View the study at Clinicaltrials.gov
A Phase III Trial of 6 vs. 12 Treatments of Adjuvant FOLFOX + Celecoxib/Placebo for Patients with Resected Stage III Colon Cancer.
View the study at Clinicaltrials.gov
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
View the study at Clinicaltrials.gov
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
View the study at Clinicaltrials.gov
A Study of Ramucirumab (IMC-1121B) Drug Product and Best Supportive Care (BSC) vs. Placebo and BSC as Second-Line Treatment in Patients with Hepatocellular Carcinoma Following First-Line Therapy with Sorafenib.
View the study at Clinicaltrials.gov
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
View the study at Clinicaltrials.gov
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
View the study at Clinicaltrials.gov
Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
View the study at Clinicaltrials.gov
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long-term Safety and Efficacy of Darbepoetin Alfa Administered at 500 µg Once-Every-3-Weeks to a Hemoglobin Ceiling of 12.0 g/dL in Anemic Subjects With Advanced Stage Non-small Cell Lung Cancer Receiving Multi-cycle Chemotherapy.
View the study at Clinicaltrials.gov
A Randomized, Phase III Study of Standard dosing vs. Longer Dosing Interval of Zolendronic Acid in Metastatic Cancer.
View the study at Clinicaltrials.gov